In summary, The various metabolic disturbances observed in MetS, including dyslipidemia, hypertension, and altered glucose metabolism, can be attributed to the abnormal physiological responses driven by elevated insulin concentrations in the insulin-resistant state. This evidence concerns the gene INS and metabolic syndrome.